科創新源(300731.SZ):募投項目結項 結餘募集資金永久補充流動資金
格隆匯10月22日丨科創新源(300731.SZ)公佈,鑑於公司原募集資金項目“高性能特種橡膠密封材料建設項目”的“生產基地建設子項目”已終止實施,為充分發揮募集資金的使用效率,最大程度發揮募集資金效能,結合公司實際經營情況,同意使用結餘募集資金及理財利息收入淨額合計1.25億元(具體金額以資金轉出當日銀行結息餘額為準)永久性補充流動資金。同時授權公司相關人員負責辦理本次專户註銷事項,相關的募集資金三方監管協議亦予以終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.